Matthew T. Roe

Overview

Best Publications

• Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

  Adrian F Hernandez;Jennifer B Green;Salim Janmohamed;Ralph B D'Agostino

  1665
  Citations

• Baseline Risk of Major Bleeding in Non–ST-Segment–Elevation Myocardial Infarction The CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) Bleeding Score

  Sumeet Subherwal;Richard G. Bach;Anita Y. Chen;Brian F. Gage

  1286
  Citations

• Prasugrel versus clopidogrel for acute coronary syndromes without revascularization

  Matthew T. Roe;Paul W. Armstrong;Keith A.A. Fox;Harvey D. White

  1068
  Citations

• Gender disparities in the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: large-scale observations from the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the American College of Cardiology/American Heart Association Guidelines) National Quality Improvement Initiative.

  Andra L. Blomkalns;Anita Y. Chen;Judith S. Hochman;Eric D. Peterson

  907
  Citations

• Association between hospital process performance and outcomes among patients with acute coronary syndromes.

  Eric D. Peterson;Matthew T. Roe;Jyotsna Mulgund;Elizabeth R. DeLong

  838
  Citations

• Trends in the Prevalence and Outcomes of Radial and Femoral Approaches to Percutaneous Coronary Intervention A Report From the National Cardiovascular Data Registry

  Sunil V. Rao;Fang Shu Ou;Tracy Y. Wang;Matthew T. Roe

  728
  Citations

• Excess Dosing of Antiplatelet and Antithrombin Agents in the Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes

  Karen P. Alexander;Anita Y. Chen;Matthew T. Roe;L. Kristin Newby

  670
  Citations

• Sex differences in mortality following acute coronary syndromes.

  Jeffrey S. Berger;Laine Elliott;Dianne Gallup;Matthew Roe

  656
  Citations

• Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative

  Deepak L. Bhatt;Matthew T. Roe;Eric D. Peterson;Yun Li

  600
  Citations

• Use of Evidence-Based Therapies in Short-Term Outcomes of ST-Segment Elevation Myocardial Infarction and Non–ST-Segment Elevation Myocardial Infarction in Patients With Chronic Kidney Disease A Report From the National Cardiovascular Data Acute Coronary Treatment and Intervention Outcomes Network Registry

  Caroline S. Fox;Paul Muntner;Anita Y. Chen;Karen P. Alexander

  559
  Citations

• Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: Rationale and design of the ODYSSEY Outcomes trial

  Gregory G. Schwartz;Laurence Bessac;Lisa G. Berdan;Deepak L. Bhatt

  538
  Citations

• Treatments, trends, and outcomes of acute myocardial infarction and percutaneous coronary intervention.

  Matthew T. Roe;John C. Messenger;William S. Weintraub;Christopher P. Cannon

  531
  Citations

• Patient Satisfaction and Its Relationship With Clinical Quality and Inpatient Mortality in Acute Myocardial Infarction

  Seth William Glickman;William Boulding;Matthew Manary;Richard Staelin

  511
  Citations

• Contemporary Mortality Risk Prediction for Percutaneous Coronary Intervention: Results from 588,398 Procedures in the National Cardiovascular Data Registry

  Eric D. Peterson;David Dai;Elizabeth R. DeLong;J. Matthew Brennan

  508
  Citations

• Pay for performance, quality of care, and outcomes in acute myocardial infarction.

  Seth W. Glickman;Fang Shu Ou;Elizabeth R. DeLong;Matthew T. Roe

  454
  Citations

• Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study

  Herbert D Aronow;Eric J Topol;Matthew T Roe;Penny L Houghtaling

  443
  Citations

• Evolution in cardiovascular care for elderly patients with non-ST-segment elevation acute coronary syndromes: Results from the CRUSADE National Quality Improvement Initiative

  Karen P. Alexander;Matthew T. Roe;Anita Y. Chen;Barbara L. Lytle

  404
  Citations

• Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome.

  Vera A. Bittner;Michael Szarek;Philip E. Aylward;Deepak L. Bhatt

  379
  Citations

• Shifting the open-artery hypothesis downstream: the quest for optimal reperfusion.

  Matthew T Roe;E.Magnus Ohman;Arthur C.P Maas;Robert H Christenson

  378
  Citations

• Sex Differences in Major Bleeding With Glycoprotein IIb/IIIa Inhibitors Results From the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the ACC/AHA Guidelines) Initiative

  Karen P. Alexander;Anita Y. Chen;L. Kristin Newby;Janice B. Schwartz

  372
  Citations